Year |
Citation |
Score |
2021 |
Svilenov HL, Sacherl J, Reiter A, Wolff LS, Cheng CC, Stern M, Grass V, Feuerherd M, Wachs FP, Simonavicius N, Pippig S, Wolschin F, Keppler OT, Buchner J, Brockmeyer C, et al. Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein. Antiviral Research. 196: 105197. PMID 34774603 DOI: 10.1016/j.antiviral.2021.105197 |
0.321 |
|
1995 |
Pippig S, Andexinger S, Lohse MJ. Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization. Molecular Pharmacology. 47: 666-76. PMID 7723728 |
0.463 |
|
1994 |
Häfner S, Adler HS, Mischak H, Janosch P, Heidecker G, Wolfman A, Pippig S, Lohse M, Ueffing M, Kolch W. Mechanism of inhibition of Raf-1 by protein kinase A. Molecular and Cellular Biology. 14: 6696-703. PMID 7935389 DOI: 10.1128/Mcb.14.10.6696 |
0.382 |
|
1993 |
Pippig S, Andexinger S, Daniel K, Puzicha M, Caron MG, Lefkowitz RJ, Lohse MJ. Overexpression of beta-arrestin and beta-adrenergic receptor kinase augment desensitization of beta 2-adrenergic receptors. The Journal of Biological Chemistry. 268: 3201-8. PMID 8381421 |
0.472 |
|
1992 |
Bauer PH, Müller S, Puzicha M, Pippig S, Obermaier B, Helmreich EJ, Lohse MJ. Phosducin is a protein kinase A-regulated G-protein regulator. Nature. 358: 73-6. PMID 1319556 DOI: 10.1038/358073A0 |
0.436 |
|
Show low-probability matches. |